Old Web
English
Sign In
Acemap
>
authorDetail
>
B. Van Eerdenbrugh
B. Van Eerdenbrugh
Katholieke Universiteit Leuven
Pharmacology
Loviride
Chemistry
Biochemistry
Transferase
4
Papers
109
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
New Potent DOT1L Inhibitors forin VivoEvaluation in Mouse.
2019
ACS Medicinal Chemistry Letters
Frédéric Stauffer
Andreas Weiss
Clemens Scheufler
Henrik Möbitz
Christian Ragot
Kim S. Beyer
Keith Calkins
Daniel Guthy
Michael Kiffe
B. Van Eerdenbrugh
Ralph Tiedt
Christoph Gaul
Show All
Source
Cite
Save
Citations (0)
New Potent DOT1L Inhibitors forin VivoEvaluation in Mouse.
2019
ACS Medicinal Chemistry Letters
Frédéric Stauffer
Andreas Weiss
Clemens Scheufler
Henrik Möbitz
Christian Ragot
Kim S. Beyer
Keith Calkins
Daniel Guthy
Michael Kiffe
B. Van Eerdenbrugh
Ralph Tiedt
Christoph Gaul
Show All
Source
Cite
Save
Citations (3)
Characterization of physico-chemical properties and pharmaceutical performance of sucrose co-freeze–dried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling
2007
International Journal of Pharmaceutics
B. Van Eerdenbrugh
Ludo Froyen
Johan A. Martens
Norbert Blaton
Patrick Augustijns
Marcus E. Brewster
G. Van den Mooter
Show All
Source
Cite
Save
Citations (106)
Nanosizing of the antiviral agent loviride for the production of oral (semi-)solid dosage forms
2006
B. Van Eerdenbrugh
Ludo Froyen
Johan Martens
Norbert Blaton
Patrick Augustijns
Marcus E. Brewster
G. Van den Mooter
Show All
Source
Cite
Save
Citations (0)
1